Mindfulness for Substance Use and Co-Occurring Disorders: Approaches, Mechanisms, and Evidence

Target audience and instructional level of this course: foundational

There is no known conflict of interest or commercial support related to this CE program.

Mindfulness-based treatment has gained much interest. This course focuses on the application of mindfulness-based treatment for substance use disorders and co-occurring disorders. The course addresses theoretical rationales for usage, clinical principles and practices as well as a review of the evidence.

Learning Objectives

After completing this training the professional will:

• describe theoretical and neurobiological rationale for the use of mindfulness-based treatment approaches for substance use disorders and co-occurring disorders.
• summarize principles and practices in the use of mindfulness-based treatment approaches for substance use disorders and co-occurring disorders.
• outline the research evidence pertaining to the use of mindfulness-based treatment approaches for substance use disorders and co-occurring disorders.

Judson A. Brewer, MD, Ph.D.
Joseph T. Smith, MD
Department of Psychiatry, Yale University School of Medicine

Sarah Bowen, Ph.D.
G. Alan Marlatt, Ph.D.
Department of Psychology, University of Washington

Marc N. Potenza, Ph.D., MD
Child Study Center, Yale University School of Medicine

Wendy Hausotter, M.Ed.
Problem Gambling Prevention Coordinator at Oregon Department of Human Services

Traci Rieckmann, PhD, NFATTC
Department of Public Health and Preventive Medicine, Oregon Health and Science University

You must be logged in to view and or take the course post test.

Click here to login